Skip to content
Shuttingdown

Bone Biologics Corp

Orthopedic, Prosthetic & Surgical Appliances & Supplies · BURLINGTON · MA

Distress signal

Moderate confidence (50%)

Updated Oct 18, 2026, 12:07 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Bone Biologics Corp was delisted from its exchange (Oct 13, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Bone Biologics Corp was delisted from its exchange

    Oct 13, 2026

    Delisting effective

    • SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001419554 Bone Biologics Corp 001-40899 2 Burlington Woods Drive, Ste 100 Burlington MA MASSACHUSETTS 01803 617 312 4862 warrant 17 CFR 240.12d2-2(a)(2) Katelin Rowe CDO Analyst 2026-10-12”

  2. Bone Biologics Corp received a delisting notice from its exchange

    Sep 10, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 10, 2026, Bone Biologics Corporation (the Company ) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that, based upon the closing bid price of the Company s common stock for the last 30 consecutive business days, the Company no longer meets Nasdaq Listing Rule 5550(a)(2), which requires listed companies to maintain a minimum bid price of at least $1 per share. Nasdaq Listing Rule 5810(c)(3)(A) provides a complian…”

Company information

Founded
—
Employees (estimate)
—
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Subindustry
—
Listing
SEC lists the tickers BBLG and BBLGW on Nasdaq.
SEC CIK
0001419554
Website
—
LinkedIn
—
Headquarters
BURLINGTON, MA
Also known as
AFH ACQUISITION X, INC., Bone Biologics, Corp.
Legal entities
Bone Biologics Corp

Sources

Every material source used to build this profile.

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    X0203 0001354457 Nasdaq Stock Market LLC 0001419554 Bone Biologics Corp 001-40899 2 Burlington Woods Drive, Ste 100 Burlington MA MASSACHUSETTS 01803 617 312 4862 warrant 17 CFR 240.12d2-2(a)(2) Katelin Rowe CDO Analyst 2026-10-12
    View source record

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Bone Biologics Corp — Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842) — BURLINGTON, MA
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 10, 2026, Bone Biologics Corporation (the Company ) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that, based upon the closing bid price of the Company s common stock for the last 30 consecutive business days, the Company no longer meets Nasdaq Listing Rule 5550(a)(2), which requires listed companies to maintain a minimum bid price of at least $1 per share. Nasdaq Listing Rule 5810(c)(3)(A) provides a complian…
    View source record

Status history

Every derived status, with the rule that produced it.

  • UNKNOWN → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 20, 2026, 12:14 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.